LeMaitre Vascular - 19 Year Stock Price History | LMAT

Historical daily share price chart and data for LeMaitre Vascular since 2006 adjusted for splits and dividends. The latest closing stock price for LeMaitre Vascular as of January 31, 2025 is 96.93.
  • The all-time high LeMaitre Vascular stock closing price was 107.97 on November 22, 2024.
  • The LeMaitre Vascular 52-week high stock price is 109.58, which is 13.1% above the current share price.
  • The LeMaitre Vascular 52-week low stock price is 57.60, which is 40.6% below the current share price.
  • The average LeMaitre Vascular stock price for the last 52 weeks is 83.19.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
LeMaitre Vascular Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 96.4705 91.4700 100.2600 91.4700 96.9300 5.20%
2024 79.4679 56.2655 107.9700 53.5767 92.1400 63.62%
2023 54.5898 44.6158 67.3249 43.9284 56.3151 24.60%
2022 45.5148 50.0355 54.7010 38.0419 45.1953 -7.39%
2021 50.3628 38.7062 61.2746 38.7062 48.8016 25.12%
2020 29.4064 34.0466 39.7464 20.0655 39.0048 14.08%
2019 28.6493 21.9990 34.4366 21.1149 34.1893 53.77%
2018 31.2505 29.0248 38.3316 20.7011 22.2341 -25.13%
2017 28.0630 23.3588 36.4378 20.2758 29.6963 26.58%
2016 15.9823 14.4895 23.5718 11.4487 23.4607 48.49%
2015 10.2850 7.0591 16.2755 6.5807 15.7992 128.79%
2014 6.7965 7.0899 7.5012 5.9284 6.9056 -2.72%
2013 5.9242 5.0147 7.6382 5.0147 7.0988 42.05%
2012 5.0930 4.9115 5.6589 4.2978 4.9973 -1.35%
2011 5.6232 5.8647 6.3748 4.5179 5.0655 -11.46%
2010 4.8548 4.2084 6.1520 3.7351 5.7210 35.40%
2009 2.7748 1.8084 4.2253 1.6140 4.2253 116.64%
2008 3.0261 5.0703 5.6703 1.5718 1.9504 -62.77%
2007 5.4771 5.1126 6.4646 4.6985 5.2393 3.33%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $2.247B $0.193B
LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $221.767B 27.38
Boston Scientific (BSX) United States $151.377B 43.52
Stryker (SYK) United States $149.082B 32.08
EssilorLuxottica (ESLOY) France $125.055B 0.00
Medtronic (MDT) Ireland $117.214B 17.41
Lonza Group Ag (LZAGY) Switzerland $45.950B 0.00
Haleon (HLN) United Kingdom $43.139B 28.03
GE HealthCare Technologies (GEHC) United States $40.136B 20.82
ResMed (RMD) United States $37.119B 30.50
Terumo (TRUMY) Japan $28.886B 41.07
Koninklijke Philips (PHG) Netherlands $25.642B 19.63
Zimmer Biomet Holdings (ZBH) United States $22.107B 14.07
Insulet (PODD) United States $19.438B 77.40
Baxter (BAX) United States $16.737B 10.89
Smith & Nephew SNATS (SNN) United Kingdom $11.065B 0.00
BellRing Brands (BRBR) United States $10.084B 40.57
Sunny Optical Technology (SNPTF) China $9.976B 0.00
Bio-Rad Laboratories (BIO) United States $9.966B 33.87
Demant (WILYY) Denmark $8.735B 0.00
Lantheus Holdings (LNTH) United States $6.433B 14.95
ICU Medical (ICUI) United States $4.121B 39.23
Prestige Consumer Healthcare (PBH) United States $3.893B 19.36
Envista Holdings (NVST) United States $3.678B 27.40
Haemonetics (HAE) United States $3.430B 16.74
Perrigo (PRGO) Ireland $3.366B 9.91
GN Store Nord (GNNDY) Denmark $3.027B 19.41
Shandong Weigao Medical Polymer (SHWGF) China $2.989B 0.00
QuidelOrtho (QDEL) United States $2.927B 18.84
Neogen (NEOG) United States $2.495B 28.75
AtriCure (ATRC) United States $2.067B 0.00
Green Thumb Industries (GTBIF) United States $1.464B 25.63
InMode (INMD) Israel $1.462B 8.79
AdaptHealth (AHCO) United States $1.430B 10.22
BioLife Solutions (BLFS) United States $1.313B 0.00
Maravai LifeSciences Holdings (MRVI) United States $1.270B 0.00
Owens & Minor (OMI) United States $1.150B 8.99
Evolus (EOLS) United States $0.922B 0.00
Phibro Animal Health (PAHC) United States $0.887B 15.64
CeriBell (CBLL) United States $0.833B 0.00
Curaleaf Holdings (CURLF) Canada $0.830B 0.00
Capricor Therapeutics (CAPR) United States $0.649B 0.00
VAREX IMAGING (VREX) United States $0.561B 24.73
Surmodics (SRDX) United States $0.511B 0.00
Omeros (OMER) United States $0.502B 0.00
Cresco Labs (CRLBF) United States $0.432B 0.00
Verano Holdings (VRNOF) United States $0.429B 0.00
Valneva SE (VALN) France $0.412B 0.00
ZimVie (ZIMV) United States $0.401B 33.77
Quanterix (QTRX) United States $0.370B 0.00
Cerus (CERS) United States $0.360B 0.00
Viemed Healthcare (VMD) United States $0.322B 30.67
Sanara MedTech (SMTI) United States $0.317B 0.00
Biote (BTMD) United States $0.309B 6.76
OraSure Technologies (OSUR) United States $0.291B 19.50
Canopy Growth (CGC) Canada $0.265B 0.00
Zynex (ZYXI) United States $0.263B 55.13
High Tide (HITI) Canada $0.239B 0.00
Sanuwave Health (SNWV) United States $0.233B 3.28
Utah Medical Products (UTMD) United States $0.208B 15.52
Aurora Cannabis (ACB) Canada $0.203B 0.00
Brainsway (BWAY) Israel $0.197B 104.70
MacroGenics (MGNX) United States $0.190B 0.00
Organigram Holdings (OGI) Canada $0.189B 0.00
TerrAscend (TSNDF) Canada $0.154B 0.00
TriSalus Life Sciences (TLSI) United States $0.149B 0.00
FitLife Brands (FTLF) United States $0.145B 18.27
Quipt Home Medical (QIPT) United States $0.135B 0.00
Jin Medical (ZJYL) China $0.125B 0.00
Fonar (FONR) United States $0.102B 11.54
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
Veru (VERU) United States $0.089B 0.00
InterCure (INCR) Israel $0.077B 0.00
Exagen (XGN) United States $0.072B 0.00
INLIF (INLF) $0.071B 0.00
Rockwell Medical (RMTI) United States $0.066B 34.00
Jushi Holdings (JUSHF) United States $0.059B 0.00
Apyx Medical (APYX) United States $0.055B 0.00
Cytosorbents (CTSO) United States $0.055B 0.00
Modular Medical (MODD) United States $0.051B 0.00
Ayr Wellness (AYRWF) United States $0.051B 0.00
United-Guardian (UG) United States $0.050B 14.35
ImmuCell (ICCC) United States $0.048B 0.00
Safety Shot (SHOT) United States $0.031B 0.00
Nephros (NEPH) United States $0.018B 0.00
Allurion Technologies (ALUR) United States $0.015B 0.00
Innovative Eyewear (LUCY) United States $0.013B 0.00
Flora Growth (FLGC) United States $0.011B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Agape ATP (ATPC) $0.005B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
Sharps Technology (STSS) United States $0.001B 0.00
SNDL (SNDL) Canada $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00